Summary of Key Information:

Acquirer / Seller / Promoter: Promoter and Promoter Group Entities

Target Company: Aarey Drugs and Pharmaceuticals Limited

Stock Exchange Listings:

  • BSE Scrip Code: Not specified in disclosure
  • NSE Scrip Code: Not specified in disclosure

Nature of Transaction / Event: Shareholding acquisition through warrant conversion

Date of Transaction: 30-09-2026

Number of Shares Affected: 2,370,000 equity shares

% of Total Shareholding / Voting Capital Affected: 7.71% of total voting capital

Mode of Transaction / Action: Preferential allotment pursuant to conversion of warrants

Consideration: Not disclosed

Shareholding / Promoter Snapshot (Before & After):

Before Transaction / Event:

Total Promoter Group Voting Rights: 10,692,442 shares (37.71% of total capital)

Individual Holdings Before:

  • Bina Rajesh Ghatalia: 4,003,584 shares (14.12%)
  • Mihir Rajesh Ghatalia: 2,835,888 shares (10.00%)
  • Nimit Rajesh Ghatalia: 1,150,000 shares (4.06%)
  • Mira Mihir Ghatalia: 690,000 shares (2.43%)
  • Ekta Nimit Ghatalia: 0 shares (0.00%)
  • Mihir Rajesh Ghatalia (HUF): 0 shares (0.00%)
  • Rajesh Pranlal Ghatalia: 2,971 shares (0.01%)
  • Nimit Impex Private Limited: 2,010,000 shares (7.09%)

After Transaction / Event:

Total Promoter Group Voting Rights: 13,062,443 shares (42.52% of total capital)

Individual Holdings After:

  • Bina Rajesh Ghatalia: 4,503,584 shares (14.66%)
  • Mihir Rajesh Ghatalia: 3,180,888 shares (10.35%)
  • Nimit Rajesh Ghatalia: 1,500,000 shares (4.88%)
  • Mira Mihir Ghatalia: 940,000 shares (3.06%)
  • Ekta Nimit Ghatalia: 500,000 shares (1.63%)
  • Mihir Rajesh Ghatalia (HUF): 245,000 shares (0.80%)
  • Rajesh Pranlal Ghatalia: 182,971 shares (0.60%)
  • Nimit Impex Private Limited: 2,010,000 shares (6.54%)

Pledged / Encumbered Shares: Not applicable to this transaction

Unencumbered Shares: Not specified

Other Noteworthy Information:

  • The disclosure is made under Regulation 29(2) read with Regulation 29(3) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
  • Equity share capital increased from 28,354,303 to 30,724,303 shares of ₹10 each
  • Total diluted share capital after conversion is 33,354,303 shares
  • The conversion involved warrants held by seven promoter group entities
  • Revised allotment date was 06-08-2026 with final allotment on 30-09-2026

Analyst Notes:

  • The transaction represents a routine warrant conversion exercise by promoter group entities
  • No change in actual economic ownership, only conversion of existing convertible instruments
  • Compliance disclosure made as required under SEBI Takeover Regulations
  • Total promoter group voting rights increased by 4.81 percentage points post-conversion